Balaxi Pharmaceuticals Ltd. - Research Center
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Sales |
19.03 |
15.90 |
12.70 |
16.55 |
25.04 |
Operating profit |
1.51 |
0.20 |
0.28 |
0.91 |
3.77 |
Interest |
0.35 |
0.51 |
0.41 |
0.36 |
0.26 |
Gross profit |
2.00 |
-0.15 |
0.90 |
1.70 |
3.64 |
EPS (Rs) |
0.25 |
-0.11 |
0.10 |
0.23 |
0.50 |
Quarterly
results in details
|
Jun' 24 |
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Other income |
0.85 |
0.16 |
1.03 |
1.15 |
0.13 |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
15.69 |
13.46 |
10.34 |
13.62 |
19.14 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
1.15 |
0.60 |
1.29 |
1.27 |
1.24 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
0.67 |
1.64 |
0.80 |
0.74 |
0.89 |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
- |
- |
- |
- |
- |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.12 |
0.12 |
0.13 |
0.13 |
0.13 |
Taxation |
0.51 |
0.31 |
0.28 |
0.39 |
0.95 |
Net profit / loss |
1.38 |
-0.58 |
0.49 |
1.18 |
2.55 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
11.04 |
10.90 |
10.23 |
10.23 |
10.23 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
7.94 |
1.25 |
2.20 |
5.52 |
15.06 |
GPM (%) |
10.08 |
-.92 |
6.54 |
9.62 |
14.46 |
NPM (%) |
6.93 |
-3.58 |
3.56 |
6.68 |
10.15 |